# Osteosarcoma: Patient Derived Xenograft Preclinical Testing

> **NIH NIH U01** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2021 · $160,233

## Abstract

Project Summary
Not Applicable

## Key facts

- **NIH application ID:** 10297249
- **Project number:** 3U01CA199221-06S2
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Richard G. Gorlick
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $160,233
- **Award type:** 3
- **Project period:** 2021-02-01 → 2021-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10297249

## Citation

> US National Institutes of Health, RePORTER application 10297249, Osteosarcoma: Patient Derived Xenograft Preclinical Testing (3U01CA199221-06S2). Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/grant/nih/10297249. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*